Skip to content
SEKISUI XenoTech DD Blog Logo

SEKISUI XenoTech Named a 2019 Top-Performing Provider on Science Exchange

Science Exchange stated, “Discovery research programs at growing biotech companies are demanding—R&D leaders must balance the need to innovate with the risk of early technology adoption and the pressure to deliver results quickly. But, with over 10,000 CROs out there, it can be challenging to find trustworthy, relevant reviews of R&D services and providers—this challenge drives thousands of scientists every day to use Science Exchange’s marketplace of 3,000+ prequalified, fully contracted providers.”

Science Exchange surveyed these scientists on the challenges they face and compiled a list of top-performing, trending providers in the most requested service categories based on responsiveness, productivity, and requester endorsements. SEKISUI XenoTech ranked in the top 5 providers for Pharmacology services, not just because of our binding and inhibition assays but for our full suite of in vitro and in vivo ADME/PK & DDI services.

We take great pride in the service, quality and expertise that we provide our customers, and are deeply gratified to hear about the feedback that Science Exchange has received about us. Learn more about our research services and test systems and let us know how we can assist your drug development efforts.

Learn more about:

About the Authors

Michael Millhollen received his bachelor's degree in Visual Communications from the University of Kansas and has over 20 years of experience in marketing and communications. As Global Marketing Manager, he is dedicated to the objective of sharing SEKISUI XenoTech’s scientific expertise and knowledge with scientists around the world.

Subscribe to our Newsletter

Stay up to date with our news, events and research

In vitro pipette test article treatment
005 International Messaging Created with Sketch.

Do you have a question or a request for upcoming blog content?

We love to get your feedback

A scientist utlilizing a microplate